However, in prostate or breast cancer, TRPV6 is definitively associated with highly proliferative and metastatic tumours [27, 28] thus, the combination of both highly expressed calcium receptors may have affected the different timing of tumour development and progression that we observed. Here, TRPV6 is linked to metastatic neoplasm.